AUPO410796A0 - Method of treating benign prostatic hyperplasia - Google Patents

Method of treating benign prostatic hyperplasia

Info

Publication number
AUPO410796A0
AUPO410796A0 AUPO4107A AUPO410796A AUPO410796A0 AU PO410796 A0 AUPO410796 A0 AU PO410796A0 AU PO4107 A AUPO4107 A AU PO4107A AU PO410796 A AUPO410796 A AU PO410796A AU PO410796 A0 AUPO410796 A0 AU PO410796A0
Authority
AU
Australia
Prior art keywords
benign prostatic
prostatic hyperplasia
treating benign
treating
hyperplasia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO4107A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Peptide Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Technology Ltd filed Critical Peptide Technology Ltd
Priority to AUPO4107A priority Critical patent/AUPO410796A0/en
Publication of AUPO410796A0 publication Critical patent/AUPO410796A0/en
Priority to ES97936524T priority patent/ES2285737T3/en
Priority to EP97936524A priority patent/EP1007080B1/en
Priority to NZ334236A priority patent/NZ334236A/en
Priority to CA2264562A priority patent/CA2264562C/en
Priority to PCT/AU1997/000560 priority patent/WO1998008533A1/en
Priority to DK97936524T priority patent/DK1007080T3/en
Priority to AU39345/97A priority patent/AU713413B2/en
Priority to AT97936524T priority patent/ATE359805T1/en
Priority to DE69737635T priority patent/DE69737635T2/en
Priority to CN971975485A priority patent/CN1216636C/en
Priority to US09/242,635 priority patent/US6337318B1/en
Priority to JP51105398A priority patent/JP3860841B2/en
Priority to HK00101268A priority patent/HK1022275A1/en
Priority to US09/991,714 priority patent/US6777386B2/en
Priority to US10/808,504 priority patent/US7309689B2/en
Abandoned legal-status Critical Current

Links

AUPO4107A 1996-08-30 1996-12-06 Method of treating benign prostatic hyperplasia Abandoned AUPO410796A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AUPO4107A AUPO410796A0 (en) 1996-12-06 1996-12-06 Method of treating benign prostatic hyperplasia
JP51105398A JP3860841B2 (en) 1996-08-30 1997-09-01 Sustained peptide release formulation
DK97936524T DK1007080T3 (en) 1996-08-30 1997-09-01 Formulation for sustained release of peptide agonists and analogues of GnRH
AT97936524T ATE359805T1 (en) 1996-08-30 1997-09-01 SUSTAINED RELEASE FORMULATION OF GNRH PEPTIDE AGONISTS AND ANALOGS
NZ334236A NZ334236A (en) 1996-08-30 1997-09-01 Composition comprising GnRH, lecithin and stearin
CA2264562A CA2264562C (en) 1996-08-30 1997-09-01 Sustained peptide-release formulation
PCT/AU1997/000560 WO1998008533A1 (en) 1996-08-30 1997-09-01 Sustained peptide-release formulation
ES97936524T ES2285737T3 (en) 1996-08-30 1997-09-01 PROLONGED RELEASE FORM OF GNRH AGEPISTS AND PEPTIDAL ANALOGS.
AU39345/97A AU713413B2 (en) 1996-08-30 1997-09-01 Sustained peptide-release formulation
EP97936524A EP1007080B1 (en) 1996-08-30 1997-09-01 Formulation for the sustained release of peptide agonists and analogues of GnRH
DE69737635T DE69737635T2 (en) 1996-08-30 1997-09-01 Delayed release formulation of peptide agonists and analogs of GnRH
CN971975485A CN1216636C (en) 1996-08-30 1997-09-01 Titanium slow-release composition
US09/242,635 US6337318B1 (en) 1996-08-30 1997-09-01 Sustained GnRH peptide-release formulation
HK00101268A HK1022275A1 (en) 1996-08-30 2000-02-29 Sustained peptide-release formulation.
US09/991,714 US6777386B2 (en) 1996-08-30 2001-11-26 Sustained peptide-release formulation
US10/808,504 US7309689B2 (en) 1996-08-30 2004-03-25 Sustained peptide-release formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO4107A AUPO410796A0 (en) 1996-12-06 1996-12-06 Method of treating benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
AUPO410796A0 true AUPO410796A0 (en) 1997-01-09

Family

ID=3798415

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO4107A Abandoned AUPO410796A0 (en) 1996-08-30 1996-12-06 Method of treating benign prostatic hyperplasia

Country Status (1)

Country Link
AU (1) AUPO410796A0 (en)

Similar Documents

Publication Publication Date Title
AU6393896A (en) Method for treating benign prostatic hyperplasia with thermal therapy
AU6578998A (en) Method of treatment of migraine
AU5173296A (en) Prostatic tissue expander
AU9214398A (en) Compositions and methods for treating water
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU2235395A (en) Biological markers of benign prostate hyperplasia
AU4518897A (en) Method of treating atherosclerosis
ZA952763B (en) Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
AU9016898A (en) Methods and compositions for treatment of restenosis
AU4003597A (en) Methods of diagnosing and treating cancer
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
HU9501286D0 (en) Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
AU2251897A (en) Method of treating liver disorders
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
AU6883398A (en) Methods of treating bone loss
EP0633781A4 (en) Compositions and methods for treating benign prostatic hypertrophy.
AU2051397A (en) Method of treating alopecia
AU2337997A (en) Method of treating cancer using c-26 modified bryostatin
AU5457694A (en) Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
AU2243897A (en) Methods of treating or preventing pain or nociception
AUPO410796A0 (en) Method of treating benign prostatic hyperplasia
AU4027097A (en) Method of treatment
AU4816896A (en) Treatment and prevention of prostatic cancer
AU6172896A (en) Melatonin agonists for treating benign prostatic hyperplasia
AU2002336520A1 (en) Method of treating benign prostatic hyperplasia and other beingn porstate conditions